Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women

Inclusion Criteria: * Healthy research participants, with an active sexual life; * Intact skin and mucosa in the test region; * Participants vaccinated for COVID-19 (Corona virus Disease). * Agreement to adhere to the study procedures and requirements and attend the institute on the day(s) and time(s) determined for the assessments; * Ability to consent to participate in the study; * Menopausal participants of any age, without systemic or topical hormone replacement therapy in the last 6 months * Presenting mild to moderate vaginal dryness (≥0.5 and \<7.5) - according to the Visual Analogic Scale * Healthy research participants, with an active sex life (at least once a week) Exclusion Criteria: * Skin pathology in the area of product application; * Decompensated Diabetes Mellitus (TBD by the institute together with the sponsor); * Immune insufficiency; * Current use of the following topical or systemic medications: corticosteroids, immunosuppressants and antihistamines; * Skin diseases: vitiligo, psoriasis, atopic dermatitis; * Previous reaction to the category of the product tested; * Other illnesses or medications that may directly interfere with the study or put the health of the research participant at risk. * Have used vaginal moisturizing creams and/or intimate lubricants 5 days before the initial study visit; * Have had sexual intercourse at least 48 hours before the initial study visit; * Have been diagnosed with a urogenital or vaginal infection in the last 30 days; * Have used topical or systemic antibiotics, antifungals, hormone-based creams or treatment for vaginal atrophy in the last 30 days.